What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

DNA Methylation Decrease Gene Expression: Mechanisms and Impact

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to DNA Methylation and Gene Expression

What is DNA Methylation?

DNA methylation is a covalent chemical modification in which a methyl group (–CH₃) is transferred to the fifth carbon position of the cytosine pyrimidine ring, producing 5-methylcytosine (5mC). This reaction is catalyzed by a family of enzymes called DNA methyltransferases (DNMTs), using S-adenosylmethionine (SAM) as the methyl donor. In mammalian somatic cells, methylation occurs almost exclusively at cytosine residues that are followed by a guanine nucleotide—the so-called CpG dinucleotide. Approximately 70–80% of all CpG dinucleotides in the human genome are methylated, but the distribution is far from uniform.

The genome contains regions called CpG islands—stretches of DNA typically 300–3,000 base pairs long with a high GC content (greater than 50%) and a high observed-to-expected CpG ratio (greater than 0.6). Approximately 60–70% of human gene promoters are associated with CpG islands. In normal cells, most CpG islands at promoter regions remain unmethylated, regardless of whether the associated gene is active or inactive. In contrast, CpG dinucleotides outside of CpG islands—such as those in repetitive elements, transposons, and gene bodies—are heavily methylated.

The functional consequence of DNA methylation depends entirely on genomic context. When methylation occurs at a gene promoter, particularly within a CpG island, it is strongly associated with transcriptional repression. This relationship between promoter methylation and gene silencing is so robust that it serves as a central paradigm in epigenetics: DNA methylation decreases gene expression by creating a chromatin environment that is incompatible with transcription initiation.

Gene Expression Basics

Gene expression is the process by which information encoded in DNA is converted into functional products, primarily proteins. The first step, transcription, is carried out by RNA polymerase II (Pol II) and requires the assembly of a pre-initiation complex at the promoter. This complex includes general transcription factors such as TFIID, which binds to the TATA box or initiator elements, and TFIIB, which helps recruit Pol II. Transcription factors that bind to specific DNA sequences—enhancers and promoters—either activate or repress transcription by recruiting co-activators or co-repressors that modify chromatin structure.

Chromatin is the packaged form of DNA in the nucleus, consisting of DNA wrapped around histone octamers to form nucleosomes. The accessibility of DNA to transcription factors and Pol II is governed by chromatin state. Actively transcribed genes are associated with open chromatin, marked by histone acetylation (e.g., H3K27ac) and trimethylation of histone H3 at lysine 4 (H3K4me3) at promoters. Repressed genes are associated with compact chromatin, marked by histone methylation at lysine 9 (H3K9me3) or lysine 27 (H3K27me3). DNA methylation is intimately connected to these histone modifications, and together they form a regulatory network that determines whether a gene is expressed or silenced.

The Mechanism: How DNA Methylation Decreases Gene Expression

DNA methylation represses transcription through two broad, non-mutually exclusive mechanisms: direct interference with transcription factor binding, and indirect repression via the recruitment of methyl-CpG-binding proteins that remodel chromatin.

Direct Interference with Transcription Factor Binding

Some transcription factors recognize DNA sequences that contain CpG dinucleotides. When the cytosine within the recognition motif is methylated, the methyl group protrudes into the major groove of the DNA double helix, creating steric hindrance that prevents the transcription factor from making sequence-specific contacts with the DNA. This effectively blocks the binding of activating transcription factors, thereby preventing transcription initiation.

A well-characterized example is the transcription factor CTCF (CCCTC-binding factor), which plays roles in chromatin organization and gene insulation. CTCF binding is highly sensitive to DNA methylation at its recognition site; methylation of even a single CpG within the CTCF motif abolishes binding. Another example is the E-box motif (CANNTG) recognized by basic helix-loop-helix transcription factors such as MYC and USF. Methylation of the CpG within the E-box prevents binding of these activators, contributing to gene silencing.

However, direct interference is not the dominant mechanism for most genes. Many promoters that are silenced by DNA methylation do not have transcription factor binding sites that overlap with CpG dinucleotides. Instead, repression is achieved through the second, indirect mechanism.

Recruitment of Methyl-CpG-Binding Proteins

The methyl group on cytosine is recognized by a family of proteins known as methyl-CpG-binding domain (MBD) proteins. These include MeCP2, MBD1, MBD2, MBD3, and MBD4. These proteins specifically bind to symmetrically methylated CpG dinucleotides and recruit additional protein complexes that repress transcription.

MeCP2 is the founding member of this family and was originally identified as a protein that binds specifically to methylated CpG dinucleotides. MeCP2 contains a methyl-CpG-binding domain (MBD) that recognizes 5mC and a transcriptional repression domain (TRD) that interacts with the co-repressor complex Sin3a and histone deacetylases (HDACs). The recruitment of HDACs leads to the removal of acetyl groups from histone tails, resulting in a more compact chromatin structure that is refractory to transcription.

MBD2 is a component of the NuRD (nucleosome remodeling and deacetylase) complex, which combines histone deacetylase activity with ATP-dependent chromatin remodeling. The NuRD complex uses the energy of ATP hydrolysis to slide or eject nucleosomes, further compacting the chromatin and occluding the promoter from transcription factor access.

MBD1 recruits the SETDB1 histone methyltransferase, which deposits H3K9me3—a histone mark associated with constitutive heterochromatin. This creates a positive feedback loop: DNA methylation recruits H3K9 methyltransferases, and H3K9me3 in turn recruits the DNMTs that maintain DNA methylation, reinforcing the silenced state.

Chromatin Remodeling and Histone Modifications

The recruitment of MBD proteins and their associated co-repressor complexes leads to a cascade of chromatin modifications that collectively establish a repressive chromatin state. Histone deacetylation removes the acetyl groups that neutralize the positive charge on histone lysine residues, allowing the histone tails to interact more tightly with the negatively charged DNA backbone. This compacts the nucleosome array and reduces the accessibility of the promoter to the transcription machinery.

Histone methylation at H3K9 and H3K27 further stabilizes the repressed state. H3K9me3 is recognized by heterochromatin protein 1 (HP1), which promotes the formation of higher-order chromatin structures characteristic of constitutive heterochromatin. H3K27me3, deposited by the Polycomb repressive complex 2 (PRC2), is associated with facultative heterochromatin and developmental gene silencing.

The relationship between DNA methylation and histone modifications is bidirectional. While DNA methylation can direct histone modifications through MBD proteins, histone modifications can also direct DNA methylation. For example, the histone methyltransferase G9a can recruit DNMT3A and DNMT3B to deposit de novo methylation at specific loci. This cross-talk ensures that the repressed state is robust and heritable through cell divisions.

Where Does DNA Methylation Occur? Promoters, Gene Bodies, and Enhancers

The effect of DNA methylation on gene expression is highly dependent on the genomic location of the methylated cytosines. Methylation at promoters, gene bodies, and enhancers has distinct—and sometimes opposing—consequences.

CpG Islands and Promoter Methylation

Promoter CpG islands are the most well-studied targets of DNA methylation-mediated repression. In normal cells, promoter CpG islands are maintained in an unmethylated state, even for genes that are not expressed. This is because the unmethylated state is actively protected by the presence of H3K4me3, which recruits the protein Cfp1 (CXXC finger protein 1) that in turn protects the region from DNMT activity.

When promoter CpG islands become methylated—as occurs during development, cellular differentiation, or in disease states such as cancer—the gene is stably silenced. The density of methylation matters: partial methylation of a CpG island has a weaker repressive effect than dense methylation. Typically, methylation of 50–80% of the CpG sites within a promoter CpG island is required to achieve robust transcriptional repression.

The mechanism of repression at methylated promoters involves both the blockade of transcription factor binding and the recruitment of MBD proteins. Additionally, methylated CpG islands are often associated with the loss of H3K4me3 and the gain of H3K9me2/3, further stabilizing the silenced state.

Gene Body Methylation and Alternative Splicing

Methylation within the transcribed region of a gene—the gene body—has a different relationship with gene expression. Gene body methylation is positively correlated with transcription: actively transcribed genes tend to have higher levels of methylation in their gene bodies than silent genes. This is thought to reflect the passage of Pol II through the gene, which recruits DNMTs to maintain methylation at CpG sites that are transiently exposed during transcription.

Gene body methylation may also play a role in regulating alternative splicing. The MBD protein MeCP2 can bind to methylated exons and recruit HDACs, which slow the elongation rate of Pol II. This pausing provides more time for the splicing machinery to recognize weak splice sites, thereby promoting exon inclusion. Conversely, loss of gene body methylation can lead to exon skipping. This illustrates that the relationship between DNA methylation and gene expression is not a simple on/off switch but involves nuanced regulation of transcript diversity.

Enhancer Methylation

Enhancers are regulatory DNA elements that can be located thousands of base pairs away from their target promoters. They bind transcription factors and co-activators to stimulate transcription. Enhancer activity is associated with specific histone marks, including H3K4me1 and H3K27ac.

DNA methylation at enhancers is generally associated with reduced enhancer activity. Methylation of CpG sites within enhancer regions can block the binding of transcription factors that are required for enhancer function, such as CTCF or tissue-specific factors. In embryonic stem cells, enhancers that are poised but not yet active tend to have intermediate levels of methylation, and demethylation of these enhancers is required for their activation during differentiation.

The relationship between enhancer methylation and gene expression is context-dependent. Some enhancers are methylated without any effect on the expression of their target genes, suggesting that the presence of other activating signals can override the repressive effect of methylation. However, in many cases, enhancer methylation is a reliable marker of inactive regulatory elements.

Evidence Linking DNA Methylation to Gene Silencing

The repressive role of DNA methylation is supported by a wealth of experimental evidence from multiple biological contexts.

Imprinting and X-Chromosome Inactivation

Genomic imprinting is a phenomenon in which a subset of genes is expressed exclusively from either the maternal or paternal allele. This allele-specific expression is controlled by differentially methylated regions (DMRs) that are established during gametogenesis. For example, the imprinted gene H19 is expressed only from the maternal allele, while the neighboring IGF2 gene is expressed only from the paternal allele. The imprinting control region (ICR) upstream of H19 is methylated on the paternal allele, which prevents the binding of CTCF and allows an enhancer to activate IGF2 on the paternal chromosome. On the maternal allele, the ICR is unmethylated, CTCF binds, and the enhancer is insulated from IGF2, allowing H19 to be expressed. This demonstrates that DNA methylation at a regulatory element directly determines allele-specific gene expression.

X-chromosome inactivation is another classic example. In female mammals, one of the two X chromosomes is silenced to achieve dosage compensation. The inactive X chromosome (Xi) is characterized by dense DNA methylation at promoter CpG islands of X-linked genes, along with the presence of H3K27me3 and the long non-coding RNA XIST. The maintenance of X inactivation requires the continued activity of DNMT1; loss of DNMT1 in somatic cells leads to reactivation of some X-linked genes, confirming that DNA methylation is required to maintain the silenced state.

Tumor Suppressor Gene Silencing in Cancer

Cancer cells frequently exhibit aberrant hypermethylation of promoter CpG islands at tumor suppressor genes, leading to their silencing. This is functionally equivalent to a loss-of-function mutation, but it is epigenetic and potentially reversible. Well-documented examples include the silencing of CDKN2A (encoding p16^INK4a^), MLH1 (a DNA mismatch repair gene), and BRCA1 (a DNA repair gene) in various cancers.

The causal role of DNA methylation in silencing these genes has been demonstrated by treating cancer cells with demethylating agents such as 5-azacytidine or 5-aza-2′-deoxycytidine (decitabine). These nucleoside analogs are incorporated into DNA during replication and covalently trap DNMTs, leading to their degradation and passive demethylation of the genome. Treatment with these agents reactivates the expression of silenced tumor suppressor genes, providing direct evidence that DNA methylation is responsible for their repression.

Knockout Studies of DNA Methyltransferases

Genetic ablation of DNMTs in mice has provided definitive evidence for the role of DNA methylation in gene silencing. Dnmt1 knockout mice die during embryogenesis, and embryonic stem cells lacking DNMT1 exhibit massive loss of global DNA methylation and derepression of many genes, including imprinted genes and endogenous retroviruses. Dnmt3a and Dnmt3b double knockout mice also die early in development, and Dnmt3b mutations in humans cause immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome, a disease characterized by hypomethylation of pericentromeric repeats.

These knockout studies demonstrate that DNA methylation is essential for the establishment and maintenance of gene silencing during development and in adult tissues.

Methods to Study DNA Methylation and Gene Expression

Several techniques are available to detect DNA methylation and to correlate it with gene expression changes. The choice of method depends on the scale of the study, the resolution required, and the available resources.

Bisulfite Sequencing and Methylation Arrays

Bisulfite conversion is the gold standard for detecting 5mC. Treatment of DNA with sodium bisulfite deaminates unmethylated cytosines to uracil, while methylated cytosines are protected and remain as cytosine. After PCR amplification and sequencing, the presence of a cytosine at a CpG site indicates that it was methylated in the original sample; a thymine indicates that it was unmethylated.

Whole-genome bisulfite sequencing (WGBS) provides single-nucleotide resolution of DNA methylation across the entire genome. Reduced representation bisulfite sequencing (RRBS) enriches for CpG-rich regions, making it a cost-effective alternative for promoter-focused studies. Methylation arrays, such as the Illumina Infinium HumanMethylationEPIC BeadChip, measure methylation at approximately 850,000 CpG sites across the genome and are widely used in large cohort studies.

Methylation-Specific PCR

Methylation-specific PCR (MSP) is a rapid, low-cost method to assess the methylation status of a specific CpG island. After bisulfite conversion, two sets of primers are designed: one set that anneals to the bisulfite-converted sequence of methylated DNA (retaining cytosines) and one set that anneals to the converted sequence of unmethylated DNA (where cytosines became uracils and then thymines after PCR). The presence of a PCR product with the methylated primers indicates methylation at the target region. MSP is qualitative or semi-quantitative and is commonly used to screen for promoter methylation of tumor suppressor genes in clinical samples.

RNA-Seq and Integrative Analysis

To correlate DNA methylation with gene expression, RNA sequencing (RNA-seq) is performed on the same samples. RNA-seq quantifies transcript levels across the genome, providing a direct measure of gene expression. Integrative analysis of methylation and expression data can identify genes whose expression is inversely correlated with promoter methylation. Tools such as the R package methylKit or DMRcate can identify differentially methylated regions (DMRs), and these can be overlapped with differentially expressed genes from RNA-seq analysis. For students familiar with differential expression analysis, the same statistical frameworks—such as those used in Differential Gene Expression Analysis Deseq2 or Differential Gene Expression Dge Analysis—can be adapted to methylation data. Standard workflows in Differential Gene Expression Analysis in R often include steps to integrate methylation and expression data.

DNA Methylation vs. Histone Modifications: A Complex Interplay

DNA methylation does not act in isolation. It is one layer of a multi-layered regulatory system that includes histone modifications, chromatin remodelers, and non-coding RNAs.

Cross-Talk Between DNA Methylation and Histone Marks

The relationship between DNA methylation and histone modifications is bidirectional and cooperative. As described earlier, MBD proteins recruit HDACs and histone methyltransferases, establishing a repressive histone code. Conversely, histone modifications can influence DNA methylation patterns. For example, the presence of H3K4me3 at promoters protects them from de novo methylation by DNMT3A and DNMT3B, because the PWWP domain of DNMT3A/B binds preferentially to H3K36me3, not H3K4me3. The CXXC domain of DNMT1 also protects CpG islands from methylation by binding to unmethylated CpG dinucleotides.

The Polycomb repressive complex 2 (PRC2), which deposits H3K27me3, can recruit DNMTs to some loci, leading to de novo methylation. This is particularly relevant in cancer, where Polycomb-marked genes are at high risk of becoming aberrantly hypermethylated. However, the relationship is not universal; many Polycomb-repressed genes remain unmethylated in normal cells, indicating that additional factors determine whether H3K27me3 leads to DNA methylation.

The Role of TET Enzymes in Demethylation

DNA methylation is not permanent. The ten-eleven translocation (TET) family of enzymes—TET1, TET2, and TET3—catalyze the oxidation of 5mC to 5-hydroxymethylcytosine (5hmC), then to 5-formylcytosine (5fC), and finally to 5-carboxylcytosine (5caC). These oxidized derivatives can be passively diluted during DNA replication or actively removed by thymine DNA glycosylase (TDG) through the base excision repair pathway, restoring unmethylated cytosine.

TET enzymes are particularly important in embryonic development, where they mediate the genome-wide demethylation that occurs after fertilization. They also play roles in adult tissues, where they maintain the hypomethylated state of promoter CpG islands. Loss of TET function, particularly TET2, is common in hematological malignancies and is associated with hypermethylation of tumor suppressor genes. The dynamic interplay between DNMTs and TET enzymes ensures that DNA methylation patterns are responsive to developmental and environmental cues, as discussed in Gene Expression Change Over Time.

Common Pitfalls and Misconceptions

Students frequently encounter several misconceptions when studying DNA methylation. Understanding these pitfalls is essential for accurate interpretation of experimental data.

Not All Methylation Is Repressive

The statement "DNA methylation decreases gene expression" is an oversimplification. While promoter methylation is generally repressive, gene body methylation is positively correlated with transcription. Methylation at some regulatory elements, such as insulators, can have activating effects by blocking the binding of repressive factors. Moreover, methylation at intergenic regions and repetitive elements serves primarily to silence transposons and maintain genomic stability, rather than to regulate specific genes. Therefore, the effect of DNA methylation must always be interpreted in its genomic context.

Methylation Is Dynamic, Not Static

DNA methylation was historically viewed as a stable, irreversible mark. This view is incorrect. The discovery of TET enzymes and active demethylation pathways has shown that DNA methylation is dynamically regulated. Methylation patterns change during development, cellular differentiation, and in response to environmental stimuli. Even in post-mitotic neurons, DNA methylation is actively turned over at specific loci. Students should avoid thinking of methylation as a permanent off switch; it is better conceptualized as a tunable dial that can be adjusted in response to cellular signals.

Correlation vs. Causation in Studies

Many studies report correlations between DNA methylation and gene expression. For example, a gene with high promoter methylation may have low expression. However, correlation does not establish causation. The methylation may be a consequence of gene silencing rather than its cause. To establish causation, researchers must use experimental approaches such as targeted demethylation (e.g., using dCas9-TET1 fusions) or DNMT inhibition. Students should be critical when reading the literature and distinguish between studies that demonstrate correlation and those that demonstrate causation.

Technical Artifacts in Bisulfite Conversion

Bisulfite conversion is not 100% efficient. Incomplete conversion of unmethylated cytosines can lead to false-positive methylation calls. Conversely, over-conversion can lead to false-negative calls. Standard protocols recommend including conversion efficiency controls (e.g., unmethylated lambda phage DNA) and using a conversion rate of >98% as a quality threshold. Additionally, PCR bias can amplify methylated or unmethylated alleles preferentially, skewing results. These technical issues underscore the importance of validating methylation findings with independent methods.

Practical Summary: Key Takeaways for Exams

Core Concepts

DNA methylation is a covalent modification of cytosine residues at CpG dinucleotides, catalyzed by DNMTs using SAM as the methyl donor. Promoter CpG island methylation is strongly associated with transcriptional repression. The mechanisms include direct blockade of transcription factor binding and indirect repression via MBD proteins that recruit HDACs and histone methyltransferases. DNA methylation is essential for genomic imprinting, X-chromosome inactivation, and silencing of transposable elements. Aberrant promoter methylation silences tumor suppressor genes in cancer, and demethylating agents can reactivate these genes.

Important Exceptions

Not all methylation is repressive. Gene body methylation is associated with active transcription and can influence alternative splicing. Methylation at some regulatory elements can be activating. DNA methylation is dynamic, with TET enzymes catalyzing active demethylation. The relationship between methylation and expression is context-dependent and must be evaluated on a gene-by-gene basis.

Study Tips

When studying DNA methylation, focus on the following points:

Know the enzymes: DNMT1 (maintenance), DNMT3A/3B (de novo), TET1/2/3 (demethylation).
Understand the difference between CpG islands and non-island CpG sites.
Be able to explain the two mechanisms of methylation-mediated repression.
Recognize the genomic contexts where methylation is repressive versus permissive.
Be familiar with the key techniques: bisulfite sequencing, MSP, methylation arrays, and RNA-seq integration.
Understand the evidence from imprinting, X-inactivation, and cancer.

Frequently Asked Questions

Does DNA methylation decrease gene expression?

Yes, when it occurs at gene promoters, particularly within CpG islands. Dense promoter methylation is strongly associated with transcriptional repression. However, methylation at other genomic locations, such as gene bodies, does not decrease gene expression and may even be associated with active transcription.

How does DNA methylation decrease gene expression?

DNA methylation decreases gene expression through two main mechanisms. First, it can directly block the binding of transcription factors that require unmethylated CpG dinucleotides in their recognition sequences. Second, methyl-CpG-binding domain proteins such as MeCP2 and MBD2 bind to methylated DNA and recruit co-repressor complexes, including histone deacetylases and chromatin remodelers, which compact chromatin and prevent transcription initiation.

Why does DNA methylation decrease gene expression?

The primary biological purpose of promoter methylation is stable gene silencing. This is essential for processes such as genomic imprinting, X-chromosome inactivation, silencing of transposable elements, and tissue-specific gene repression during development. In disease, aberrant methylation of tumor suppressor gene promoters contributes to cancer development by silencing genes that normally protect against uncontrolled cell growth.

Is DNA methylation always associated with gene silencing?

No. The relationship between DNA methylation and gene expression depends on genomic context. Promoter methylation is generally repressive, but gene body methylation is associated with active transcription. Methylation at enhancers can reduce enhancer activity, but some enhancers are methylated without affecting target gene expression. Additionally, methylation at repetitive elements primarily serves to maintain genome stability rather than to regulate specific genes.

What is the role of CpG islands in DNA methylation?

CpG islands are GC-rich regions, often located at gene promoters, that are normally maintained in an unmethylated state. When CpG islands become methylated, the associated gene is typically silenced. The unmethylated state of CpG islands is actively protected by the presence of H3K4me3 and the CXXC domain-containing protein Cfp1, which prevents DNMT access. In cancer, aberrant methylation of promoter CpG islands is a common mechanism of tumor suppressor gene silencing.

How can DNA methylation be reversed?

DNA methylation can be reversed passively or actively. Passive demethylation occurs when DNMT1 is inhibited or absent during DNA replication, leading to dilution of methylation marks in daughter cells. Active demethylation is mediated by TET enzymes, which oxidize 5mC to 5hmC, 5fC, and 5caC. These oxidized forms can be removed by thymine DNA glycosylase (TDG) and the base excision repair pathway, restoring unmethylated cytosine. Pharmacologically, nucleoside analogs such as 5-azacytidine and decitabine inhibit DNMTs and cause passive demethylation.

What techniques are used to measure DNA methylation?

Common techniques include bisulfite sequencing (whole-genome or reduced representation), methylation arrays (e.g., Illumina EPIC), methylation-specific PCR, and pyrosequencing. Bisulfite conversion is the foundation of most methods, as it distinguishes methylated from unmethylated cytosines. For correlating methylation with gene expression, RNA-seq is performed on the same samples and integrated with methylation data using bioinformatics tools.

Key Takeaways

DNA methylation is the covalent addition of a methyl group to cytosine at CpG dinucleotides, catalyzed by DNMTs.
Promoter CpG island methylation represses transcription by blocking transcription factor binding and recruiting MBD proteins that remodel chromatin.
The repressive effect of DNA methylation is context-dependent: promoter methylation silences, gene body methylation correlates with active transcription, and enhancer methylation generally reduces enhancer activity.
DNA methylation is essential for imprinting, X-inactivation, and transposon silencing; its disruption causes developmental defects and cancer.
DNA methylation is dynamic and reversible, with TET enzymes catalyzing active demethylation.
Key techniques include bisulfite sequencing, methylation arrays, MSP, and integrative analysis with RNA-seq.
Not all methylation is repressive, and correlation between methylation and expression does not prove causation.